Description:
The Boston Zoning Commission is charged with maintaining the Boston Zoning Code. In order to fulfill that responsibility, the Commission meets on a regular basis to adopt map and text changes to the Code. Anyone may petition the Zoning Commission to adopt a map or text change.
Typically the Boston Planning & Development Agency, after a public dialogue, petitions the Zoning Commission to adopt such changes. After a petition is authorized by the BPDA Board, a public notice of a hearing before the Zoning Commission is advertised in the Boston Herald and local newspapers at least 20 days in prior to the hearing.
This meeting will be held virtually and not in person. You can participate in this meeting by going to: bit.ly/3ixmlmK. You may also submit written comments or questions to [email protected].
Agenda
|
Public Hearings |
|
9:00 AM |
Map Amendment Application No. 735
Planned Development Area No. 129, Jan Karski Way, Dorchester
Map 5A/5B, Dorchester Neighborhood District
Said map amendment would amend “Map 5A/5B, Dorchester Neighborhood District,” by adding the designation “D,” indicating a Planned Development Area overlay district to approximately 169,158 square feet (approximately 3.88 acres) of land generally bounded by Jan Karski Way on the west, Enterprise Street on the south, Boston Street on the east, and three-family and commercial parcels sharing the block to the north. The proposed Development Plan includes an approximately 341,176 gross square foot transit-oriented residential development, creating approximately 403 new rental housing units, and includes 14,665 gross square feet of retail space, and significant improvements to the public realm.
|
|
9:15 AM |
First Amendment to the Development Plan for Planned Development Area No. 106
1000 Washington Street and 321 Harrison Avenue, South End
Said First Amendment amends the Development Plan to establish a review process for any proposed Research and Development Use on the site which would operate at BioSafety Level 3, as established by the U.S. Department of Health and Human Services (each, a "BSL-3 Sub-Use").
|